Walgreen Company March Results Outpace Rite Aid Corporation's

Both Walgreen and Rite Aid reported March sales today; once again Walgreen saw much higher growth than Rite Aid.

Apr 3, 2014 at 11:57AM

Today Rite Aid (NYSE:RAD) and Walgreen (NASDAQ:WBA) each reported sales for March, and the two drugstore chains had dramatically different results.

Walgreen announced that its comparable sales -- a metric measuring sales at stores that have been open for more than a year -- rose by 3.5%, and Rite Aid noted its same-store sales increased by less than one quarter of that amount at just 0.7%.

Each firm disclosed that its front-end sales decreased as a result of the timing of the Easter holiday -- on April 20 of this year versus March 31 of last year: Walgreen front-end sales fell 3.4% and Rite Aid's fell 5%. Rite Aid said the timing of the holiday was responsible for a 4.1% reduction in sales, whereas Walgreen did not disclose a specific amount in its press release.

In addition the firms both reported that pharmacy same-store sales rose, but once again the difference between the two was dramatic. Rite Aid saw its pharmacy sales rise by 3.5%, but suggested this was negatively affected by 1.3 percentage points as a result of the introduction of generic drugs. Walgreen noted its same-store pharmacy sales overall increased by 8%, but said it saw a drop of 1.6 percentage points from generic drugs.

Walgreen also noted it saw a positive impact of 0.9 percentage points from the timing of the calendar days, as March this year had one additional Monday and one less Friday versus 2013. Rite Aid did not disclose whether or not its pharmacy sales were positively or negatively affected by the shifting days.

Rite Aid saw its same-store total prescription count increase by 1.1% and Walgreen saw its prescriptions rise by 5.1%. In total, prescriptions accounted for 69.4% of sales at Rite Aid and 64.7% of sales at Walgreen.

Rite Aid was also outpaced by Walgreen in February, as its same-store -sales rose by 1.5%, whereas the comparable store sales at Walgreen rose by 4.5%.

Walgreen and Rite Aid are the nation's largest and third-largest drugstore chains, respectively, based on the number of stores. Walgreen had 8,221 drugstores at the end of last month, while Rite Aid operated 4,584. The second-largest, CVS Caremark Corp., which has more than 7,600 CVS/pharmacy stores, doesn't report monthly sales publicly. 

-- Material from The Associated Press was used in this report.


Patrick Morris has no position in any stocks mentioned. The Motley Fool recommends CVS Caremark. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

4 in 5 Americans Are Ignoring Buffett's Warning

Don't be one of them.

Jun 12, 2015 at 5:01PM

Admitting fear is difficult.

So you can imagine how shocked I was to find out Warren Buffett recently told a select number of investors about the cutting-edge technology that's keeping him awake at night.

This past May, The Motley Fool sent 8 of its best stock analysts to Omaha, Nebraska to attend the Berkshire Hathaway annual shareholder meeting. CEO Warren Buffett and Vice Chairman Charlie Munger fielded questions for nearly 6 hours.
The catch was: Attendees weren't allowed to record any of it. No audio. No video. 

Our team of analysts wrote down every single word Buffett and Munger uttered. Over 16,000 words. But only two words stood out to me as I read the detailed transcript of the event: "Real threat."

That's how Buffett responded when asked about this emerging market that is already expected to be worth more than $2 trillion in the U.S. alone. Google has already put some of its best engineers behind the technology powering this trend. 

The amazing thing is, while Buffett may be nervous, the rest of us can invest in this new industry BEFORE the old money realizes what hit them.

KPMG advises we're "on the cusp of revolutionary change" coming much "sooner than you think."

Even one legendary MIT professor had to recant his position that the technology was "beyond the capability of computer science." (He recently confessed to The Wall Street Journal that he's now a believer and amazed "how quickly this technology caught on.")

Yet according to one J.D. Power and Associates survey, only 1 in 5 Americans are even interested in this technology, much less ready to invest in it. Needless to say, you haven't missed your window of opportunity. 

Think about how many amazing technologies you've watched soar to new heights while you kick yourself thinking, "I knew about that technology before everyone was talking about it, but I just sat on my hands." 

Don't let that happen again. This time, it should be your family telling you, "I can't believe you knew about and invested in that technology so early on."

That's why I hope you take just a few minutes to access the exclusive research our team of analysts has put together on this industry and the one stock positioned to capitalize on this major shift.

Click here to learn about this incredible technology before Buffett stops being scared and starts buying!

David Hanson owns shares of Berkshire Hathaway and American Express. The Motley Fool recommends and owns shares of Berkshire Hathaway, Google, and Coca-Cola.We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

©1995-2014 The Motley Fool. All rights reserved. | Privacy/Legal Information

Compare Brokers